IIM
INBX icon

INTECH Investment Management’s Inhibrx INBX Stock Holding History

INTECH Investment Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206K Buy
+2,172
New +$218K ﹤0.01% 1781
2026
Q1 		– Sell
-3,242
Closed -$256K – 2228
2025
Q4 		$256K Buy
+3,242
New +$221K ﹤0.01% 1848

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

INTECH Investment Management's INBX Position: Q2 2026 in Review

INTECH Investment Management opened a new position in Inhibrx (INBX) in Q2 2026: 2,172 shares worth $206K. The stake represents ﹤0.01% of the portfolio and ranks #1781 among its holdings. This is a return to the name: INTECH Investment Management previously reported a position in INBX as recently as Q4 2025.

INTECH Investment Management first reported a position in INBX in Q4 2025 and has held it in 2 quarters since. The position peaked at $256K in Q4 2025. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • INTECH Investment Management held 2,172 shares of Inhibrx worth $206K as of Q2 2026.
  • Inhibrx was a new INTECH Investment Management position in Q2 2026.
  • Inhibrx made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1781 holding.
  • INTECH Investment Management first reported a position in Inhibrx in Q4 2025 and has held it in 2 quarters since.
  • INTECH Investment Management's Inhibrx position peaked at $256K in Q4 2025.
  • 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.